Outcome of Board meeting held on 13.11.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 1.1 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved unaudited results for the quarter and half-year ended September 30, 2025. Revenue from operations stood at zero across all reported periods, with the company recording only employee benefits and overhead expenses. Net loss for Q2 FY26 was ₹21.13 lakhs, widening to ₹47.42 lakhs for H1 FY26 versus a ₹39.14 lakh loss in H1 FY25. The balance sheet shows deeply negative net worth of approximately ₹(3,636.73) lakhs, with total borrowings of around ₹3,729.68 lakhs against almost negligible cash. Cash flow from operations was negative at ₹(38.36) lakhs, funded by additional borrowings of ₹39.61 lakhs. The company explicitly stated it is relying on a promoter comfort letter to continue as a going concern.
This is a deeply concerning filing for shareholders – the company has no operating revenue, accumulating losses, negative net worth, and depends entirely on promoter support and new borrowings to stay afloat. The stock is effectively a non-operating, loss-making shell relying on promoter backing, posing significant solvency and going-concern risk.